Lupin launches fixed dose triple combo inhaler for COPD in India

The product is an important addition to Lupin’s respiratory portfolio.
More news in Industry
CDK Global appoints Sudhakar Ramakrishna CEO
Gradiant bets big on India, secures five contracts, including semiconductor fab
Granules eyes first to file status, 180 days exclusivity on generic cancer drug Ruxolitinib in U.S.